Verified Nov 2026
Other
·

Shanghai, Shanghai
·
Since 1998
MicroPort Scientific Corporation, founded in 1998 and headquartered in Shanghai, manufactures medical devices across cardiovascular, orthopedic, neurovascular, and surgical robotics sectors. The private company operates in over 90 countries with 5,000-10,000 employees and annual revenue between $500M-$1B. In August 2026, its Aorfix Endograft System received NMPA Green Channel designation for medical devices.
MicroPort at a glance
Revenue
$500M-1B
Est. band
Employees
5,000-10,000
Founded
1998
Headquarters
Shanghai, Shanghai
Certifications
ISO 13485
Import activity
21
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
21
Named foreign suppliers
10
Top origins
China

Shared foreign counterparties do not establish that these companies buy from MicroPort.
What this tells a buyer
MicroPort recorded 21 documented shipments with primary supply originating from China, including internal subsidiaries Suzhou Microport Orthorecon and Shanghai Microport Orthopedics.
The company holds ISO 13485 certification and maintains a portfolio of over 300 medical device types including stents, pacemakers, MRI-compatible implants, and robotic-assisted surgical platforms.
MicroPort serves more than 20,000 hospitals globally and operates regional headquarters in the USA and France alongside its Shanghai base.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
28 years in operation (founded 1998).
21 US import shipments on record.
Holds ISO 13485 certification(s) per public sources.
Overview
MicroPort Scientific Corporation, founded in 1998 and headquartered in Shanghai, manufactures medical devices across cardiovascular, orthopedic, neurovascular, and surgical robotics sectors. The private company operates in over 90 countries with 5,000-10,000 employees and annual revenue between $500M-$1B. In August 2026, its Aorfix Endograft System received NMPA Green Channel designation for medical devices.
At a glance
Attribute | Detail |
|---|---|
Founded | 1998 |
Headquarters | Shanghai, Shanghai |
Employees | 5,000-10,000 |
Revenue | $500M-1B (estimated) |
Certifications | ISO 13485 |
What MicroPort makes
The company holds ISO 13485 certification and maintains a portfolio of over 300 medical device types including stents, pacemakers, MRI-compatible implants, and robotic-assisted surgical platforms.
Certifications
MicroPort is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — microport.com
Trade and customs footprint
MicroPort recorded 21 documented shipments with primary supply originating from China, including internal subsidiaries Suzhou Microport Orthorecon and Shanghai Microport Orthopedics. US customs bill-of-lading records list 21 inbound shipments across 10 foreign suppliers, with top origins including China.
Latest developments
2026-08-27 — MicroPort® Endovastec™’s Aorfix™ Endograft System Granted NMPA Green Channel Designation for Innovative Medical Devices (microport.com)
2026-07-17 — Potential Sale of Shanghai MicroPort Orthopedics to Tinavi | ORTHOWORLD (orthoworld.com)
2026-06-20 — The Aga Khan University Hospital has successfully signed two MoUs with global leaders MicroPort and Smith+Nephew to introduce advanced robotic surgery systems into its main operating rooms. | The Aga Khan University Hospital (Pakistan) (linkedin.com)
2026-06-09 — OYMotion and MicroPort NeuroScientific Enter Strategic Cooperation_
IN THE NEWS (oymotion.com)2026-04-06 — MicroPort CardioFlow Launches LBBOT Solution in Europe & Australia (microport.com)
2025-12-21 — MicroPort® CardioFlow and MicroPort® CRM Complete Strategic Merger: Launching a New Era in Heart Failure Treatment (microport.com)
Facilities
MicroPort is headquartered in Shanghai, Shanghai. Public sources also reference these locations:
France — microport.com
Company details
MicroPort serves more than 20,000 hospitals globally and operates regional headquarters in the USA and France alongside its Shanghai base. MicroPort was founded in 1998, has an estimated 5,000-10,000 employees, and is headquartered in Shanghai, Shanghai. On the LightSource stability read it is rated "Established & active": 28 years in operation (founded 1998). 21 US import shipments on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does MicroPort do?
MicroPort Scientific Corporation, founded in 1998 and headquartered in Shanghai, manufactures medical devices across cardiovascular, orthopedic, neurovascular, and surgical robotics sectors. The private company operates in over 90 countries with 5,000-10,000 employees and annual revenue between $500M-$1B. In August 2026, its Aorfix Endograft System received NMPA Green Channel designation for medical devices.
Where is MicroPort headquartered?
MicroPort is headquartered in Shanghai, Shanghai.
When was MicroPort founded?
MicroPort was founded in 1998.
How big is MicroPort?
MicroPort has an estimated 5,000-10,000 employees, with revenue in the $500M-1B range (estimated).
What certifications does MicroPort hold?
MicroPort lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Does MicroPort import from overseas suppliers?
US customs bill-of-lading records show 21 inbound shipments for MicroPort, with top origins including China.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
